Latest
Oak Therapeutics touts study results for dissolvable strips
Oak Therapeutics, based in Oxnard, announced that it completed a study of the use of its dissolvable strips to administer an anti-tuberculosis treatment orally. A 300 milligram dose of isoniazid on the dissolvable strips given to canines entered the bloodstream at a statistically similar rate to commercial tablets, the study found. The company, a subsidiary Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
